The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $9.21 in the prior trading day, Evolus Inc (NASDAQ: EOLS) closed at $9.2, down -0.11%. In other words, the price has decreased by -$0.11 from its previous closing price. On the day, 1.12 million shares were traded. EOLS stock price reached its highest trading level at $9.625 during the session, while it also had its lowest trading level at $9.0.
Ratios:
Our goal is to gain a better understanding of EOLS by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.16 and its Current Ratio is at 2.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on April 17, 2025, initiated with a Buy rating and assigned the stock a target price of $21.
On January 29, 2024, Barclays Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $10 to $16.
On June 23, 2022, Needham started tracking the stock assigning a Buy rating and target price of $18.Needham initiated its Buy rating on June 23, 2022, with a $18 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 13 ’25 when MOATAZEDI DAVID sold 111,323 shares for $10.05 per share. The transaction valued at 1,119,141 led to the insider holds 381,509 shares of the business.
MOATAZEDI DAVID sold 16,582 shares of EOLS for $164,054 on Jun 16 ’25. The insider now owns 364,927 shares after completing the transaction at $9.89 per share. On Jun 16 ’25, another insider, DAVID MOATAZEDI, who serves as the Officer of the company, bought 16,582 shares for $9.89 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EOLS now has a Market Capitalization of 593175488 and an Enterprise Value of 656127168. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.15. Its current Enterprise Value per Revenue stands at 2.382 whereas that against EBITDA is -23.892.
Stock Price History:
The Beta on a monthly basis for EOLS is 0.98, which has changed by -0.16287535 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, EOLS has reached a high of $17.82, while it has fallen to a 52-week low of $8.67. The 50-Day Moving Average of the stock is -9.26%, while the 200-Day Moving Average is calculated to be -27.58%.
Shares Statistics:
The stock has traded on average 1.08M shares per day over the past 3-months and 968270 shares per day over the last 10 days, according to various share statistics. A total of 64.45M shares are outstanding, with a floating share count of 57.03M. Insiders hold about 11.55% of the company’s shares, while institutions hold 84.38% stake in the company. Shares short for EOLS as of 1749772800 were 10605286 with a Short Ratio of 9.84, compared to 1747267200 on 9235364. Therefore, it implies a Short% of Shares Outstanding of 10605286 and a Short% of Float of 16.8.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The market rating for Evolus Inc (EOLS) is a result of the insights provided by 3.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.06, with high estimates of $0.01 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.01 and -$0.22 for the fiscal current year, implying an average EPS of -$0.13. EPS for the following year is $0.59, with 5.0 analysts recommending between $0.94 and $0.39.
Revenue Estimates
7 analysts predict $82.18M in revenue for the current quarter. It ranges from a high estimate of $86.38M to a low estimate of $80M. As of the current estimate, Evolus Inc’s year-ago sales were $66.91MFor the next quarter, 7 analysts are estimating revenue of $85.31M. There is a high estimate of $91.18M for the next quarter, whereas the lowest estimate is $82.3M.
A total of 7 analysts have provided revenue estimates for EOLS’s current fiscal year. The highest revenue estimate was $353.73M, while the lowest revenue estimate was $345.1M, resulting in an average revenue estimate of $348.21M. In the same quarter a year ago, actual revenue was $266.27MBased on 7 analysts’ estimates, the company’s revenue will be $463.84M in the next fiscal year. The high estimate is $485M and the low estimate is $444.3M.
